Intra-Cellular Therapies makes Caplyta, a once-daily pill for adults with schizophrenia and bipolar-related depression ...

Johnson & Johnson said on Monday it would buy neurological drugmaker Intra-Cellular Therapies for $14.6 billion, its biggest ...

Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Tim ...

Terence Flynn, an analyst from Morgan Stanley, maintained the Hold rating on Johnson & Johnson (JNJ – Research Report). The associated ...

Our Top PicksMost AffordableIRIS Easy Flip from Consumer CellularBest Medical Alert CapabilitiesJitterbug Flip2 from ...

Barclays PLC raised its holdings in shares of United States Cellular Co. (NYSE:USM – Free Report) by 10.8% in the 3rd quarter ...

After years of aiming for the dinner plate, cultivated meat leaders are rethinking their approach, shifting focus from direct ...

StockNews.com upgraded shares of United States Cellular (NYSE:USM – Free Report) from a sell rating to a hold rating in a research note published on Saturday. Other analysts have also recently issued ...

The Internet of the Environment (IoE) module from LI-COR Environmental enables real-time data access and analytics for key environmental processes, including core meteorological measurements as well ...

Skylo, the pioneer in Non-Terrestrial Network (NTN) communications, announced today that it has unlocked global satellite connectivity potential for more than a billion devices across a broad spectrum ...

There has been tremendous interest in cell-based meat, not least for its touted long-term potential to aid world food security.